StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Sees Significant Decline in Short Interest

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) was the target of a large drop in short interest in August. As of August 31st, there was short interest totalling 13,400 shares, a drop of 33.3% from the August 15th total of 20,100 shares. Based on an average daily volume of 11,000 shares, the days-to-cover ratio is currently 1.2 days.

StageZero Life Sciences Price Performance

Shares of SZLSF stock remained flat at $0.08 during trading hours on Monday. The stock had a trading volume of 12 shares, compared to its average volume of 8,746. StageZero Life Sciences has a 1-year low of $0.00 and a 1-year high of $1.00. The stock has a 50-day simple moving average of $0.03 and a two-hundred day simple moving average of $0.03.

StageZero Life Sciences Company Profile

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood.